
Keith Andrew Chan, MD
@keithachanmd
Followers
523
Following
5K
Media
303
Statuses
2K
Cardiology | Interventional Fellowship Grad from #NUHCS | Cebu, Philippines 🇵🇭 | Tweets are my own |
Cebu City, Philippines
Joined June 2016
RT @DrDamluji: Preventive percutaneous coronary intervention for non-flow-limiting vulnerable atherosclerotic coronary plaques in diabetes:….
0
63
0
RT @GreggWStone: NEW! 2025 US guidelines for the management of ACS (STEMI and NSTE-ACS) just released. Intravascular imaging guidance with….
0
108
0
RT @RichardAFerraro: Below NSTEMI teaching by Elias Hanna is among the best I've ever seen. Incredible teaching, relevant to providers acro….
0
61
0
RT @dr_benoy_n_shah: Agree with @SabineBleiziff2. This is straightforward . Bicuspid AS needs a RCT of TAVI vs SAVR. Until then, TAVI shoul….
0
11
0
Another challenging case at @ChhHeart .61/M, CTO of RCA, tx as HF - under the tutelage of Dr. Shozo Ishihara in collab with @ShimadzuAP and @terumoisuk .#cardiotwitter #Cardiology #CTO .@APSIC6 @APSCYoung
1
1
4
RT @radcliffeCARDIO: 🌟Join Dr @mirvatalasnag for her key highlights from this year's #TCT2024 conference. Watch Now 🔗 .
0
12
0
Wonderful review of the DCB BIF trial by Dr @aayshacader!.Will we see a further use of dcbs in more complex coronary anatomy? .#Cardiology.
#TCT2024 Late-breaking trials. @aayshacader reviews ✍️ the results 📊of the DCB-BIF Trial presented by Shao-Liang Chen in Washington:. A comparison of noncompliant balloon 🎈 with drug-coating balloon angioplasties for side branch after provisional stenting for patients with
0
4
5
Will we see a paradigm shift in the way valve disease is managed? Awesome thread!.#cardiology.
Tomorrow - Oct 28th - we learn the results of 3 landmark randomised studies in patients with aortic stenosis (AS). Results of EARLY-TAVR, EVOLVED & TAVR UNLOAD will be unveiled at #TCT2024 in a Joint LBCT Session with #NEJM. These could well be practice-changing studies. A 🧵
0
0
2
Now ongoing at #hkvalve 2024.A spotlight at lifetime care for Tav-in-tav with Rr @GilbertTangMD!.@APSCYoung @APSIC6 .#structuralheart #tavr
0
1
3
RT @denisamuraru: First prospective study at Johns Hopkins on >1000 pts w/ #echofirst and #RHC data to define grades of severity of echo-ba….
0
35
0
Seeing the wonderful HK skyline again! Looking forward to #hongkongvalve 2024!.@GilbertTangMD @MichaelChiangCS
0
0
2
Truly an evolving field!.Kudos dr @mirvatalasnag.
#ACCIC @ACCinTouch @JACCJournals . Current challenges & future paradigms of interventional training. Future Training Pathways in PCI: Interventional Critical Care, Complex Coronary Interventions & Interventional Heart Failure. @SarasVallabhMD @KDBoudoulas @perc_surgeon
0
0
2
RT @MichaelChiangCS: Just published in JACC Intervention! (Possibly First-in-Asia) Transcaval Impella-Assisted CHIP-PCI and Transcaval TAVR….
0
8
0
A groundbreaking addition to #aictpcr for tavr/tavi operators and fellows!.
Step by step guided Realistic Pumping heart model TAVR simulation session at #AictPCR. The perfect platform for aspired TAVR implanters/fellows #tavr. @keithachanmd @MichaelChiangCS @DrAnkushG @IndahSP_MD @jeremyquah88 @Ditongaje @PCRonline
0
1
2
Dr @jeremyquah88 interviews Datu/Dr Rosli - this year's Chien Foundation awardee during #aictpcr.
Just after receiving his Lifetime achievement award 🏆and looking back at his career, Course Director Mohd Ali Rosli shares a few memorable moments! .An interview by @jeremyquah88 at #AictPCR 🇸🇬 @APSIC6
0
3
4
Late repost!.A quick overview of this year's #aictpcr with course director Prof Tan Huay Cheem of the #nuhcs.
🎥What to expect this year at #AictPCR? Get the insights from Huay Cheem Tan, one of the Course Directors, interviewed by @keithachanmd! .@APSIC6
0
0
2
Coming out of the #WIN_APSIC session🚺 at #AictPCR where they presented complications cases in women, @DrSaritaRao2 & @IndahSP_MD discuss the specific symptoms of CVD in women, the impact on clinical outcomes and how to improve the management of these patients ⤵️ @APSIC6
0
1
4
A record breaking #aictpcr year!.
🎯2024 was a remarkable year for clinical cases at #AictPCR, with over 300 submissions breaking records! In this interview, @Ditongaje and @MichaelChiangCS discuss the significance of this achievement and why participation is crucial for #interventionalcardiology fellows!
0
0
1